The restrictions on the use of mitomycin preparations from Medac GmbH for intravenous administration are lifted
2023.08.17
Active substance: mitomycine
Medac GmbH informs about the lifting of the restrictions on the use of its mitomycin preparations for intravenous administration. Thus, all mitomycin preparations of Medac GmbH are again approved for intravenous administration without the use of a particle filter. The related Direct Healthcare Professional Communication (DHPC) dated November 1, 2021, which informed about this restriction of use, has been lifted.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN